Canaccord lowered the firm’s price target on Enovis (ENOV) to $58 from $70 and keeps a Buy rating on the shares. The firm said they posted a solid Q2 beat and noted the company maintained expectations to be FCF positive for the FY25 while CEO Damien McDonald outlined a vision focused on margin expansion, cash flow improvement, and disciplined execution through the EGX operating system.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV: